600739.SH
Liaoning Cheng Da Co., Ltd.
SSE · Healthcare · Medical - Distribution · CN
CNY 9.75
+0.00%Year over year
Reported trailing growth
- Revenue
- -13.4%
- EBITDA
- —
- EBIT
- -46.5%
- EPS
- +104.1%
- Free cash flow
- -48.6%
- Operating cash flow
- -36.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -11.1%
- EBITDA
- -28.1%
- EBIT
- -37.4%
- Net income
- -15.6%
- EPS
- -15.7%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026